Terrapeutics Pharma
Ness Ziona, Israel· Est.
Israeli biotech unlocking nature‑derived scaffolds to drug undruggable targets, with a focus on RAS oncology and infectious diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Israeli biotech unlocking nature‑derived scaffolds to drug undruggable targets, with a focus on RAS oncology and infectious diseases.
OncologyInfectious Diseases
Technology Platform
A nature‑derived drug discovery platform that mines soil microbial metabolites using metagenomics, high‑throughput screening, and computational design to target undruggable proteins.
Opportunities
Access to a massive, untapped natural product space offers the potential to generate first‑in‑class therapeutics for high‑unmet‑need targets such as RAS‑driven cancers and resistant infections.
Risk Factors
Technical challenges in translating natural product hits into drug‑like candidates and the long timeline required to move pre‑clinical assets into clinical development.
Competitive Landscape
Few companies focus on systematic mining of soil microbiomes for undruggable targets, giving Terrapeutics a differentiated niche despite competition from larger natural‑product and synthetic biology firms.